- Report
- June 2022
- 46 Pages
Canada
From €1926EUR$1,950USD£1,602GBP
- Report
- May 2022
- 53 Pages
Latin America
From €2716EUR$2,750USD£2,260GBP
- Report
- May 2022
- 66 Pages
Asia Pacific
From €2716EUR$2,750USD£2,260GBP
- Report
- May 2022
- 55 Pages
Middle East, Africa
From €2716EUR$2,750USD£2,260GBP
- Report
- May 2022
- 60 Pages
Europe
From €2716EUR$2,750USD£2,260GBP
- Report
- May 2022
- 60 Pages
North America
From €2716EUR$2,750USD£2,260GBP
- Report
- March 2022
- 160 Pages
Global
From €4691EUR$4,750USD£3,903GBP
- Training
- October 2021
- 2 Days
Global
From €1678EUR$1,699USD£1,396GBP
- Report
- August 2018
- 142 Pages
China
From €2133EUR$2,160USD£1,775GBP
- Training
- 8 Hours
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
United States
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
- Report
- March 2024
- 80 Pages
Global
From €3500EUR$3,796USD£3,014GBP
The Active Pharmaceutical Ingredient (API) market is a key component of the pharmaceutical manufacturing industry. APIs are the active ingredients in drugs that are responsible for their therapeutic effects. They are produced through chemical synthesis, biotechnological processes, or extraction from natural sources. APIs are then formulated into finished dosage forms such as tablets, capsules, and injectables.
The API market is highly regulated, with stringent quality control measures in place to ensure the safety and efficacy of the drugs. The market is also highly competitive, with many companies vying for a share of the market. Companies in the API market are typically large, multinational corporations with extensive research and development capabilities.
Some of the major players in the API market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more